Identification of Potential Biomarkers for Pain
NCT03495245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-11-19
Summary
The study investigates the potential of using serum biomarkers to assess pain in fibromyalgia patients.
Conditions
- Fibromyalgia
Sponsors & Collaborators
-
American Osteopathic Association
collaborator OTHER -
Rowan University
lead OTHER
Principal Investigators
-
Venkateswar Venkataraman, PhD · Rowan University School of Osteopathic Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-28
- Primary Completion
- 2020-09-30
- Completion
- 2021-09-30
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Autoreactive Autoantibodies on Peripheral and Central Disease Mechanisms in Fibromyalgia.
NCT07346950 ·Status: COMPLETED
-
Neurotropin Treatment of Fibromyalgia
NCT00366535 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative SSEP and EEG As Objective Pain Biomarker
NCT03495180 ·Status: WITHDRAWN ·Phase: NA
-
Fibromyalgia Study In Adults
NCT00256893 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Fibromyalgia Pain, Lifestyle Factors, and Inflammation
NCT07074275 ·Status: COMPLETED
-
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
NCT02234583 ·Status: COMPLETED ·Phase: PHASE3
-
Analgesic Response to Opioids in Patients With Fibromyalgia After Conventional Acupuncture Versus Sham Acupuncture
NCT06571110 ·Status: RECRUITING ·Phase: NA
-
Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
NCT05277025 ·Status: RECRUITING
-
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
NCT04263454 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of One Week Self-management Program in Patients With Fibromyalgia
NCT01035125 ·Status: COMPLETED ·Phase: NA
-
Diagnostic and Prognostic Salivary Biomarkers in Chronic Muscle Pain
NCT06994156 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Study of TD-9855 to Treat Fibromyalgia
NCT01693692 ·Status: COMPLETED ·Phase: PHASE2
-
"SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia
NCT05005351 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia
NCT03092726 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
NCT00080184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
NCT03249103 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Behavioral and Analgesic Trial for Fibromyalgia
NCT01598753 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Imaging Study on Biomarkers for Fibromyalgia
NCT03910010 ·Status: RECRUITING ·Phase: NA
-
A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
NCT00618956 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients
NCT04981925 ·Status: COMPLETED ·Phase: NA
-
Pain, Sleep and Gut Microbiota
NCT05494983 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
NCT03056690 ·Status: COMPLETED ·Phase: PHASE2
-
Biofeedback Training to Control Pain Processing
NCT02752386 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Physical Activity to Reduce Pain and Fatigue in Adults With Fibromyalgia
NCT00383084 ·Status: COMPLETED ·Phase: NA
-
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
NCT00357825 ·Status: COMPLETED ·Phase: PHASE2